agency NICE has concluded that Boston Scientific's HeartLogic and Medtronic's TriageHF diagnostics are "options for algorithm-based remote monitoring in people with cardiac implantable electronic ...

Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable ...

FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the ...

The Reveal LINQ monitor developed by Medtronic identifies more people who have atrial fibrillation after a cryptogenic stroke (CS) – with no identified cause – or transient ischaemic attack (TIA).

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...